Unjha Formulations Limited (BOM:531762)
24.79
+0.05 (0.20%)
At close: Jul 28, 2026
Unjha Formulations Market Cap
Unjha Formulations has a market cap or net worth of 111.07 million as of July 28, 2026. Its market cap has increased by 2.10% in one year.
Market Cap
111.07M
Enterprise Value
94.62M
Revenue
155.85M
Ranking
n/a
PE Ratio
15.79
Stock Price
24.79
ChartMarket Cap Chart
Since May 25, 2005, Unjha Formulations's market cap has increased from 51.62M to 111.07M, an increase of 115.19%. That is a compound annual growth rate of 3.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 111.07M | -0.84% |
| Dec 31, 2025 | 112.01M | -17.68% |
| Dec 31, 2024 | 136.07M | 86.43% |
| Dec 29, 2023 | 72.99M | 6.19% |
| Dec 30, 2022 | 68.73M | 42.04% |
| Dec 31, 2021 | 48.39M | 19.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Desh Rakshak Aushdhalaya | 176.65M |
| Zenith Healthcare | 174.11M |
| Norris Medicines | 155.01M |
| Rekvina Laboratories | 152.51M |
| Shamrock Industrial Company | 134.17M |
| Emmessar Biotech & Nutrition | 120.66M |
| Ortin Global | 117.09M |
| Beryl Drugs | 110.16M |